
Abstracts of the 2025 Annual Meeting of the ALEH
More infoHepatocellular carcinoma (HCC) is a fearsome neoplasia with patients at well-identified risk who require surveillance.
To identify variables that are influential in the diagnosis of hepatocellular carcinoma in at-risk individuals.
Materials and MethodsA cross-sectional descriptive study with an analytical component was conducted across three tertiary care centers between July 2024 and April 2025. A total of 291 patients at risk for HCC were included; 11 were diagnosed with HCC. Independent variables assessed included age, sex, risk group, cirrhosis etiology, serum alpha-fetoprotein (AFP), and PIVKA-II levels. HCC diagnosis served as the dependent variable. Categorical variables were summarized as frequencies and percentages; continuous variables as means and standard deviations (SD). Univariate and multivariate logistic regression analyses were performed to identify factors significantly associated with HCC.
ResultsThe mean age was 62 ± 10.3 years, with a predominance of patients aged ≤62. The most common risk group was liver cirrhosis (91.1%), with a slight predominance of females. In univariate analysis, liver cirrhosis, AFP ≥ 20 ng/mL, and PIVKA-II ≥ 28.4 ng/mL were significantly associated with HCC diagnosis. Multivariate analysis showed that these same variables were statistically significantly associated with the diagnosis of hepatocellular carcinoma.
ConclusionsIn at-risk patients, the presence of cirrhosis, elevated AFP (≥ 20 ng/mL) and elevated PIVKA-II (≥ 28.4 ng/mL) are strongly associated with the diagnosis of hepatocellular carcinoma.
Conflict of interest: None






